向阳花之光
08-25
$艾迪康控股(09860)$共建业务收入同比增长30%,四年CAGR达48%,主要受益于多家大型三甲医院项目的成功落地。展望下半年,公司计划深化与领先医疗机构的战略合作,推动更多标杆性项目落地。
免责声明:上述内容仅代表发帖人个人观点,不构成本平台的任何投资建议。
分享至
微信
复制链接
精彩评论
我们需要你的真知灼见来填补这片空白
打开APP,发表看法
APP内打开
发表看法
{"i18n":{"language":"zh_CN"},"detailType":1,"isChannel":false,"data":{"magic":2,"id":471303233638792,"tweetId":"471303233638792","gmtCreate":1756095110135,"gmtModify":1756095114928,"author":{"id":4107239966895660,"idStr":"4107239966895660","authorId":4107239966895660,"authorIdStr":"4107239966895660","name":"向阳花之光","avatar":"https://static.tigerbbs.com/e322d38c22fa6cc88f0c102424c4a365","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":1,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":5,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p>$艾迪康控股(09860)$共建业务收入同比增长30%,四年CAGR达48%,主要受益于多家大型三甲医院项目的成功落地。展望下半年,公司计划深化与领先医疗机构的战略合作,推动更多标杆性项目落地。<br></p></body></html>","htmlText":"<html><head></head><body><p>$艾迪康控股(09860)$共建业务收入同比增长30%,四年CAGR达48%,主要受益于多家大型三甲医院项目的成功落地。展望下半年,公司计划深化与领先医疗机构的战略合作,推动更多标杆性项目落地。<br></p></body></html>","text":"$艾迪康控股(09860)$共建业务收入同比增长30%,四年CAGR达48%,主要受益于多家大型三甲医院项目的成功落地。展望下半年,公司计划深化与领先医疗机构的战略合作,推动更多标杆性项目落地。","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/471303233638792","repostId":0,"isVote":1,"tweetType":1,"viewCount":508,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["09860"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":169,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"isCommentEnd":true,"isTiger":false,"isWeiXinMini":false,"url":"/m/post/471303233638792"}
精彩评论